Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

33.57 -0.59 (-1.73%)
Official Closing Price Updated: 7:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 712,194
Open 34.03
Bid (Size) 33.21 (100)
Ask (Size) 35.00 (100)
Prev. Close 34.16
Today's Range 33.53 - 34.07
52wk Range 23.69 - 38.79
Shares Outstanding N/A
Dividend Yield 1.79%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Smith & Nephew PLC (NYSE:SNN): A Value Investment in Medical Devices ↗
Smith & Nephew (SNN) is a value investment in medical devices, with strong profitability, accelerating growth, and attractive valuation metrics. 
Via Chartmill
News headline image
Smith+Nephew comparative study1 shows  PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
From Smith & Nephew UK Ltd
Via GlobeNewswire

Performance

YTD
+2.1%
+2.1%
1 Month
+0.4%
+0.4%
3 Month
-4.4%
-4.4%
6 Month
+10.9%
+10.9%
1 Year
+40.2%
+40.2%

More News

Read More
News headline image
UFC® and Smith+Nephew announce multi-year extension of partnership
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Organogenesis Holdings (ORGO) Battles Headwinds: Can This Regenerative Medicine Innovator Stage a Comeback?
Via MarketMinute
Topics Fraud
News headline image
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Trump Administration Review Targets Medical Supply Chain Vulnerabilities ↗
Via Benzinga
Topics Economy Government Supply Chain
News headline image
Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
What Does the Market Think About Smith & Nephew? ↗
Via Benzinga
News headline image
Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Sterling Infrastructure Posts Better-Than-Expected Earnings, Joins Lemonade, DigitalOcean Holdings, Lattice Semiconductor And Other Big Stocks Moving Higher On Tuesday ↗
Via Benzinga
News headline image
Top 2 Health Care Stocks You May Want To Dump In Q3 ↗
Via Benzinga
News headline image
Why Palantir Technologies Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
A comparative sNPWT study of 10,000+ C-sections shows PICO™ sNPWT reduces complications and cuts healthcare costs by $728,000 per 1,000 patients
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
Via Benzinga
News headline image
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
From Smith & Nephew UK Ltd
Via GlobeNewswire

Frequently Asked Questions

Is Smith & Nephew SNATS, Inc. Common Stock publicly traded?
Yes, Smith & Nephew SNATS, Inc. Common Stock is publicly traded.
What exchange does Smith & Nephew SNATS, Inc. Common Stock trade on?
Smith & Nephew SNATS, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Smith & Nephew SNATS, Inc. Common Stock?
The ticker symbol for Smith & Nephew SNATS, Inc. Common Stock is SNN on the New York Stock Exchange
What is the current price of Smith & Nephew SNATS, Inc. Common Stock?
The current price of Smith & Nephew SNATS, Inc. Common Stock is 33.57
When was Smith & Nephew SNATS, Inc. Common Stock last traded?
The last trade of Smith & Nephew SNATS, Inc. Common Stock was at 01/09/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.